132 related articles for article (PubMed ID: 34172069)
1. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy.
Hoffmann E; Clasen K; Frey B; Ehlers J; Behling F; Skardelly M; Bender B; Schittenhelm J; Reimold M; Tabatabai G; Zips D; Eckert F; Paulsen F
Radiat Oncol; 2021 Jun; 16(1):116. PubMed ID: 34172069
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
[TBL] [Abstract][Full Text] [Related]
3. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
[TBL] [Abstract][Full Text] [Related]
5. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
8. Integrative assessment of brain and bone invasion in meningioma patients.
Zwirner K; Paulsen F; Schittenhelm J; Gepfner-Tuma I; Tabatabai G; Behling F; Skardelly M; Bender B; Zips D; Eckert F
Radiat Oncol; 2019 Jul; 14(1):132. PubMed ID: 31358024
[TBL] [Abstract][Full Text] [Related]
9. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
11. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
[TBL] [Abstract][Full Text] [Related]
12. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
[TBL] [Abstract][Full Text] [Related]
13. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy.
Witt JS; Musunuru HB; Bayliss RA; Howard SP
J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090
[TBL] [Abstract][Full Text] [Related]
14. Encouraging early clinical outcomes with helical tomotherapy-based image-guided intensity-modulated radiation therapy for residual, recurrent, and/or progressive benign/low-grade intracranial tumors: a comprehensive evaluation.
Gupta T; Wadasadawala T; Master Z; Phurailatpam R; Pai-Shetty R; Jalali R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):756-64. PubMed ID: 21345610
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
16. Proton therapy for atypical meningiomas.
McDonald MW; Plankenhorn DA; McMullen KP; Henderson MA; Dropcho EJ; Shah MV; Cohen-Gadol AA
J Neurooncol; 2015 May; 123(1):123-8. PubMed ID: 25859843
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
18. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
[TBL] [Abstract][Full Text] [Related]
20. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma.
Lee JJB; Lee J; Yoon HI; Kim SH; Cho J; Lee KS; Chang JH; Suh CO
J Neurooncol; 2019 Sep; 144(2):333-341. PubMed ID: 31278690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
